Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 30, 2013 17:00 ET | Source: Immune Pharmaceuticals Inc

Immune Reports Total Shares Outstanding

TARRYTOWN, N.Y., Aug. 30, 2013 /PRNewswire/ -- Pursuant to the requirements of the Swedish Financial Supervisory Authority, Immune Pharmaceuticals Inc. (Nasdaq OMX Stockholm Exchange: IMNP and...
August 27, 2013 00:52 ET | Source: Immune Pharmaceuticals Inc

Immune Pharmaceuticals Restructures Secured Loan Following Completion of Merger

New Three-Year Term Enables Focus on Product Development TARRYTOWN, N.Y., Aug. 27, 2013 /PRNewswire/ -- Immune Pharmaceuticals Inc. (Nasdaq OMX Stockholm Exchange: IMNP and OTCQX:...
August 26, 2013 01:33 ET | Source: Immune Pharmaceuticals Inc

Immune Pharmaceuticals Completes Merger with EpiCept Corporation

Common Stock Trading on Nasdaq OMX Stockholm Exchange and OTCQX Trading Platform TARRYTOWN, New York, Aug. 26, 2013 /PRNewswire/ -- Immune Pharmaceuticals Inc. (Nasdaq OMX Stockholm Exchange:...
August 20, 2013 01:15 ET | Source: Immune Pharmaceuticals Inc

EpiCept Announces Reverse Stock Split and Change of Corporate Name to Immune Pharmaceuticals Inc.

TARRYTOWN, N.Y. and HERZLIYA-PITUACH, Israel, Aug. 20, 2013 /PRNewswire/ -- EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) (the "Company") and Immune Pharmaceuticals Ltd....
August 07, 2013 17:00 ET | Source: Immune Pharmaceuticals Inc

EpiCept Stockholders Overwhelmingly Approve Final Conditions to Merger with Immune Pharmaceuticals Ltd.

Almost 92% of Votes Cast in Favor of Proposals Merger Expected to close in August 2013 TARRYTOWN, N.Y., Aug. 7, 2013 /PRNewswire/ -- EpiCept Corporation (Nasdaq and Nasdaq...
August 01, 2013 00:10 ET | Source: Immune Pharmaceuticals Inc

EpiCept Reports Second Quarter 2013 Operating and Financial Results

Special August 6 Stockholder Meeting to Approve Final Conditions to Merger with Immune Pharmaceuticals TARRYTOWN, N.Y., Aug. 1, 2013 /PRNewswire/ -- EpiCept Corporation (Nasdaq OMX Stockholm...
June 20, 2013 00:56 ET | Source: Immune Pharmaceuticals Inc

EpiCept Issues Notice of Special Meeting of Stockholders on August 6 to Approve Important Aspects of the Proposed Merger with Immune Pharmaceuticals

Positive Vote Required to Enable Merger Closing Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm and OTCQX: EPCT) today issued notice that stockholders of EpiCept are invited to the Special...
June 03, 2013 00:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept Announces New Crolibulin Data Presented at ASCO 2013 Support Further Evaluation in Anaplastic Thyroid Cancer

TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that new data supporting further...
May 22, 2013 00:01 ET | Source: Immune Pharmaceuticals Inc

CEO of Immune Pharmaceuticals to Present at BioEquity Europe 2013

UPDATE ON BERTILIMUMAB DEVELOPMENT AND EPICEPT MERGER PROCESS HERZLIYA-PITUACH, Israel & TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: Immune Pharmaceuticals Ltd....
May 20, 2013 00:33 ET | Source: Immune Pharmaceuticals Inc

EpiCept Reports First Quarter 2013 Operating and Financial Results

PRELIMINARY PROXY STATEMENT FOR MERGER FILED WITH SEC TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX:...